Relative quantitation of peptides in wild-type and Cpefat/fat mouse pituitary using stable isotopic tags and mass spectrometry

Journal of Mass Spectrometry

Volumn 40, Issue 2, 2005, Pages 227-237

  Che, Fa Yun ^a   Biswas, Reeta ^a   Flicker, Lloyd D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Carboxypeptidase E; Chromogranin; Neuropeptide; Peptide processing; Proopiomelanocortin; Vasopressin

Indexed keywords

BIOSYNTHESIS; DEUTERIUM; GENES; HORMONES; LIQUID CHROMATOGRAPHY; NEUROLOGY; PROTEINS;

ISOTOPIC LABELS; MUTANTS; MUTATION; NEUROPEPTIDES;

MASS SPECTROMETRY;

[3 (2,5 DIOXOPYRROLIDIN 1 YLOXYCARBONYL)PROPYL]TRIMETHYLAMMONIUM; ACETYL BETA ENDORPHIN[1-26]; AMMONIUM DERIVATIVE; BETA ENDORPHIN; BETA ENDORPHIN DERIVATIVE; CARBONYL DERIVATIVE; CARBOXYPEPTIDASE H; DEUTERIUM; HORMONE PRECURSOR; HYDROGEN; HYPOPHYSIS HORMONE; ISOTOPE; NEUROPEPTIDE; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HYPOPHYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; MOUSE STRAIN; NONHUMAN; PEPTIDE SYNTHESIS; PEPTIDOMICS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CARBOXYPEPTIDASE H; CARBOXYPEPTIDASES; CHROMATOGRAPHY, LIQUID; DEUTERIUM; MASS SPECTROMETRY; MICE; MICE, OBESE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; TISSUE EXTRACTS;

EID: 14744275484     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.742     Document Type: Article

References (62)

1. Zhou A, Webb G, Zhu X, Steiner DF. Proteolytic processing in the secretory pathway. J. Biol. Chem. 1999; 274: 20 745.
2. Kolhekar AS, Mains RE, Eipper BA. Peptidylglycine alpha-amidating monooxygenase: an ascorbate-requiring enzyme. Methods Enzymol. 1997; 279: 35.
3. Prigge ST, Mains RE, Eipper BA, Amzel LM. New insights into copper monooxygenase and peptide amidation: structure, mechanism, and function. Cell. Mol. Life Sci. 2000; 57: 1236.
4. Seidah NG, Chretien M. In Handbook of Proteolytic Enzymes, Barrett AJ, Rawlings ND, Woessner JF (eds). Academic Press: San Diego, 1998; 349.
5. Seidah NG, Chretien M. In Handbook of Proteolytic Enzymes, Barrett AJ, Rawlings ND, Woessner JF (eds). Academic Press: San Diego, 1998; 345.
6. Fricker LD. Carboxypeptidase E. Annu. Rev. Physiol. 1988; 50: 309.
7. Reznik SE, Fricker LD. Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell. Mol. Life Sci. 2001; 58: 1790.
8. Fricker LD. In Handbook of Proteolytic Enzymes, Barrett AJ, Rawlings ND, Woessner JF (eds). Academic Press: San Diego, 1998; 1341.
9. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH. Hyperproinsulinemia in obese fat/fat mice associated with a point mutation in the carboxypeptidase E gene and reduced carboxypeptidase E activity in the pancreatic islets. Nat. Genet. 1995; 10: 135.
10. Fricker LD, Leiter EH. Peptides, enzymes, and obesity: new insights from a "dead" enzyme. Trends Biochem. Sci. 1999; 24: 390.
11. Song L, Fricker LD. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J. Biol. Chem. 1995; 270: 25 007.
12. Varlamov O, Fricker LD. Intracellular trafficking of metallocarboxypeptidase D in AtT-20 cells: localization to the trans-Golgi network and recycling from the cell surface. J. Cell Sci. 1998; 111: 877.
13. Varlamov O, Eng FJ, Novikova EG, Fricker LD. Localization of metallocarboxypeptidase D in AtT-20 cells: Potential role in prohormone processing. J. Biol. Chem. 1999; 274: 14 759.
14. Varlamov O, Wu F, Shields D, Fricker LD. Biosynthesis and packaging of carboxypeptidase D into nascent secretory vesicles in pituitary cell lines. J. Biol. Chem. 1999; 274: 14040.
15. Song L, Fricker LD. Tissue distribution and characterization of soluble and membrane-bound forms of metallocarboxy peptidase D. J. Biol. Chem. 1996; 271: 28 884.
16. Dong W, Fricker LD, Day R. Carboxypeptidase D is a potential candidate to carry out redundant processing functions of carboxypeptidase E based on comparative distribution studies in the rat central nervous system. Neuroscience 1999; 89: 1301.
17. Xin X, Varlamov O, Day R, Dong W, Bridgett MM, Leiter EH, Fricker LD. Cloning and sequence analysis of cDNA encoding rat carboxypeptidase D. DNA Cell Biol. 1997; 16: 897.
18. Fricker LD, Adelman JP, Douglass J, Thompson RC, von Strandmann RP, Hutton J. Isolation and sequence analysis of cDNA for rat carboxypeptidase E [EC 3.4.17.10], a neuropeptide processing enzyme. Mol. Endocrinol. 1989; 3: 666.
19. Varlamov O, Leiter EH, Fricker LD. Induced and spontaneous mutations at Ser202 of carboxypeptidase E: effect on enzyme expression, activity, and intracellular routing. J. Biol. Chem. 1996; 271: 13 981.
20. Rovere C, Viale A, Nahon J, Kitabgi P. Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology 1996; 137: 2954.
21. Fricker LD, Berman YL, Leiter EH, Devi LA. Carboxypeptidase E activity is deficient in mice with the fat mutation: effect on peptide processing. J. Biol. Chem. 1996; 271: 30 619.
22. fat mice: a regional difference in the involvement of carboxypeptidase E (Cpe) in pro-CCK processing. Endocrinology 1997; 138: 4034.
23. Udupi V, Gomez P, Song L, Varlamov O, Reed JT, Leiter EH, Fricker LD, Greeley GHJ. Effect of carboxypeptidase E deficiency on progastrin processing and gastrin mRNA expression in mice with the fat mutation. Endocrinology 1997; 138: 1959.
24. Lacourse KA, Friis-Hansen L, Rehfeld JF, Samuelson LC. Disturbed progastrin processing in carboxypeptidase E-deficient fat mice. FEBS Lett. 1997; 416: 45.
25. Che F-Y, Fricker LD. Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J. Mass Spectrom. 2005; 40.
26. Zhang R, Regnier FE. Minimizing resolution of isotopically coded peptides in comparative proteomics. J. Proteome Res. 2002; 1: 139.
27. Zhang R, Sioma CS, Thompson RA, Xiong L, Regnier FE. Controlling deuterium isotope effects in comparative proteomics. Anal. Chem. 2002; 74: 3662.
28. fat mice using differential isotopic tags and mass spectrometry. Anal. Chem. 2002; 74: 3190.
29. fat mice. Proteomics 2001; 1: 79.
30. Poljak A, McLean CA, Sachdev P, Brodaty H, Smythe GA. Quantification of hemorphins in Alzheimer's disease brains. J. Neurosci. Res. 2004; 75: 704.
31. Lee J, Albiston AL, Allen AM, Mendelsohn FA, Ping SE, Barrett GL, Murphy M, Morris MJ, McDowall SG, Chai SY. Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats. Neuroscience 2004; 124: 341.
32. Blishchenko EY, Sazonova OV, Kalinina OA, Yatskin ON, Philippova MM, Surovoy AY, Karelin AA, Ivanov VT. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures. Peptides 2002; 23: 903.
33. Duethman D, Dewan N, Cordon JM. Isolation of the opioid peptide Leu-Val-Val-hemorphin-7 from bronchoalveolar lavage fluid of a patient with non-small cell lung cancer. Peptides 2000; 21: 137.
34. 3H]thymidine incorporation in a neuronal cell line via the AT4 receptor. J. Neurochem. 1999; 73: 301.
35. Yatskin ON, Philippova MM, Blishchenko EY, Karelin AA, Ivanov VT. LVV- and VV- hemorphins: comparative levels in rat tissues. FEBS Lett. 1998; 428: 286.
36. fat mice. Proc. Natl. Acad. Sci. USA 2001; 98: 9971.
37. Nielsen E, Welinder BS, Madsen OD. Chromogtanin-B, a putative precursor of eight novel rat glucagonoma peptides through processing at mono-, di-, or tribasic residues. Endocrinology 1991; 129: 3147.
38. Sigafoos J, Chestnut WG, Merrill BM, Taylor LCE, Diliberto EJ, Viveros OH. Novel peptides from adrenomedullary chromaffin vesicles. J. Anat. 1993; 183: 253.
39. Fricker LD, McKinzie AA, Sun J, Curran E, Qian Y, Yan L, Patterson SD, Courchesne PL, Richards B, Levin N, Mzhavia N, Devi LA, Douglass J. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J. Neurosci. 2000; 20: 639.
40. Wei S, Feng Y, Che F-Y, Pan H, Mzhavia N, Devi L, McKenzie AA, Levin N, Richards WG, Fricker LD. Obesity and diabetes in transgenic mice expressing proSAAS. J. Endocrinol. 2004; 180: 357.
41. Svensson M, Skold K, Svenningsson P, Andren PE. Peptidomics-based discovery of novel neuropeptides. J. Proteome Res. 2003; 2: 213.
42. Smyth DG, Maruthainar K, Darby NJ, Fricker LD. C-terminal processing of neuropeptides: involvement of carboxypeptidase H. J. Neurochem. 1989; 53: 489.
43. Chen H, Jawahar S, Qian Y, Duong Q, Chan G, Parker A, Meyer JM, Moore KJ, Chayen S, Gross DJ, Glasser B, Permutt MA, Fricker LD. A missense polymorphism in the human carboxypeptidase E gene alters its enzymatic activity: possible implications in type 2 diabetes mellitus. Hum. Mutat. 2001; 18: 120.
44. Novikova EG, Eng FJ, Yan L, Qian Y, Fricker LD. Characterization of the enzymatic properties of the first and second domains of metallocarboxypeptidase D. J. Biol. Chem. 1999; 274: 28 887.
45. Eipper BA, Mains RE. Further analysis of post-translational processing of beta-endorphin in rat intermediate pituitary. J. Biol. Chem. 1981; 256: 5689.
46. Day R, Lazure C, Basak A, Boudreault A, Limperis P, Dong W, Lindberg I. Prodynorphin processing by proprotein convertase 2: cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity. J. Biol. Chem. 1998; 273: 829.
47. Marcinkiewicz M, Benjannet S, Seidah NG, Cantin M, Chretien M. The pituitary polypeptide "7B2" is associated with LH/FSH and TSH cells and is localized within secretory vesicles. Cell Tissue Res. 1987; 250: 205.
48. Martens GJ, Braks JA, Eib DW, Zhou Y, Lindberg I. The neuroendocrine polypeptide 7B2 is an endogenous inhibitor of prohormone convertase PC2. Proc. Natl. Acad. Sci. USA 1994; 91: 5784.
49. Zhu X, Lindberg I. 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity. J. Cell Biol. 1995; 129: 1641.
50. Qian Y, Devi LA, Mzhavia N, Munzer S, Seidah NG, Fricker LD. The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J. Biol. Chem. 2000; 275: 23 596.
51. Cameron A, Fortenberry Y, Lindberg I. The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett. 2000; 473: 135.
52. Wei S, Segura S, Vendrell J, Aviles FX, Lanoue E, Day R, Feng Y, Fricker LD. Identification and characterization of three members of the human metallocarboxypeptidase gene family. J. Biol. Chem. 2002; 277: 14 954.
53. Wei S, Feng Y, Kalinina E, Fricker LD. Neuropeptide-processing carboxypeptidases. Life Sci. 2003; 73: 655.
54. Davenport AP, Kuc RE. Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2. J. Cardiovasc. Pharmacol. 2000; 36: S12.
55. Nakagomi S, Kiryu-Seo S, Kiyama H. Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are coordinately induced in neurons and astrocytes respectively following nerve injury. Neuroscience 2000; 101: 441.
56. Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. Biol. Chem. 1995; 270: 15 262.
57. Ikeda S, Emoto N, Alimsardjono H, Yokoyama M, Matsuo M. Molecular isolation and characterization of novel four subisoforms of ECE-2. Biochem. Biophys. Res. Commun. 2002; 293: 421.
58. Russell FD, Davenport AP. Evidence for intracellular endothelin- converting enzyme-2 expression in cultured human vascular endothelial cells. Circ. Res. 1999; 84: 891.
59. Mzhavia N, Pan H, Che F-Y, Fricker LD, Devi LA. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. J. Biol. Chem. 2003; 278: 14 704.
60. Glembotski CC. Characterization of the peptide acetyltransferase activity in bovine and rat intermediate pituitaries responsible for the acetylation of beta-endorphin and alpha-melanotropin. J. Biol. Chem. 1982; 257: 10 501.
61. Glembotski CC. Acetylation of alpha-melanotropin and beta-endorphin in the rat intermediate pituitary. Subcellular localization. J. Biol. Chem. 1982; 257: 10 493.
62. Gibson TR, Glembotski CC. Acetylation of alpha MSH and beta-endorphin by rat neurointermediate pituitary secretory granule-associated acetyltransferase. Peptides 1985; 6: 615.